MOLDTKPAC

Mold-Tek Packaging share price & financials

Price
₹695.6
Market cap
₹2.2k Cr
Calls analysed
6
Latest concall · Q1 FY27 · call held 27 Jul 2026

Mold-Tek Packaging Limited Q1 FY27

Gross Margin 41.31%

What went well

  • Turnover crossed INR300 crores in Q1 FY27, indicating strong top-line performance.
  • Per kg EBITDA significantly increased to INR46.7, surpassing the historical INR40-42 range, driven by consolidation efforts and improved efficiencies.
  • High-value segments like Pharma (41% value, 38% volume growth) and Food & FMCG (24.2% volume growth) showed robust expansion.

What to watch

  • Lube segment volume declined by 17% due to base oil unavailability, impacting overall volume growth.
  • Qpack segment growth was only 2% in volume, attributed to price sensitivity and increased raw material costs affecting key industries.
Read the full call →

What Mold-Tek Packaging Limited does

Mold-Tek Packaging manufactures rigid plastic packaging - pails, containers, closures and labels - using injection moulding and its pioneered in-mold labelling (IML) process, in which a photographic label is fused into the container wall during moulding for a fully recyclable, tamper-evident finish. It is backward-integrated into its own tool room, designing and building its own moulds and robots in-house, which gives it a cost edge in the packaging industry. It sells to branded manufacturers across the paints, lubricants, food & FMCG and pharmaceutical industries, with long-standing supply relationships with customers such as Asian Paints, Castrol, Shell, Hindustan Unilever and Mondelez.

Segments

  • Paints
  • Lubricants (Lubes)
  • Food & FMCG
  • Pharma Packaging
  • Q-Pack / Bulk Packs (Square Packs)
Installed injection moulding capacity
63,000 TPA
Manufacturing units
10 plants across 8 Indian states (Telangana, Maharashtra, Karnataka, Tamil Nadu, Haryana, Uttar Pradesh, Andhra Pradesh, Dadra & Nagar Haveli and Daman & Diu)
ISO certified plants
10
Injection moulding machines
175+
In-house designed and built moulds/robots
1000+
Stock points (depots)
2, pan-India
Founded 1986Headquarters Jubilee Hills, Hyderabad, Telangana, India Company website

Guidance record · Q1 FY27

what the last two calls moved 24 tracked 4 delivered 3 missed 17 open
  • ROCE went quiet said Q4 FY26 Promised: 13.5-14% Q1 FY27: Not mentioned in the earnings call.
  • EBITDA per kg revised up said Q4 FY26 Promised: INR42.5-43 Q1 FY27: Achieved Rs 46.7 in Q1. Raised full-year guidance to Rs 44-45.
  • Pharma Revenue delivered said Q4 FY25 Promised: Rs 30-35 crores for FY26 Q4 FY26: Achieved Rs 34.4 crores for FY26

All 24 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue up 24.5%, net profit up 18.2% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue191 191 203 241 210 +10%198 +4%238 +17%300 +24%
EBITDA34 34 38 47 39 +15%38 +12%48 +26%56 +19%
Net profit14 14 16 22 15 +7%14 +0%21 +31%26 +18%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −17.9% 1Y

₹500₹600₹700₹800Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q2 FY26 — 4 Nov 2025Q3 FY26 — 9 Feb 2026Q4 FY26 — 11 May 2026Q1 FY27 — 27 Jul 2026

1Y: ₹824.35 on 10 Sept 2025 → ₹676.45. High ₹832.4 (18 Sept 2025), low ₹472.65 (24 Mar 2026).

How the price took the results

close before → close after

Q1 FY27
−4.8%
27 Jul
Q4 FY26
−1.3%
11 May
Q3 FY26
+0.9%
9 Feb
Q2 FY26
+1.1%
4 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue grew 6.7% a year over 3 years, FY23 to FY26. Operating margin widened to 19.4%.

Year endingFY23FY24FY25FY26
Revenue₹731 Cr₹698 Cr₹782 Cr₹887 Cr
Operating profit₹135 Cr₹133 Cr₹142 Cr₹172 Cr
Operating margin18.5%19.1%18.2%19.4%
Interest₹4 Cr₹8 Cr₹14 Cr₹17 Cr
Depreciation₹29 Cr₹38 Cr₹49 Cr₹59 Cr
Net profit₹80 Cr₹67 Cr₹61 Cr₹72 Cr
Net margin10.9%9.6%7.8%8.1%
Cash from operations₹152 Cr₹79 Cr₹110 Cr₹125 Cr
Free cash flow₹5 Cr₹-56 Cr₹-33 Cr₹7 Cr
ROCE19.0%14.0%12.0%13.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹14 Cr₹16 Cr₹17 Cr₹17 Cr₹17 Cr₹17 Cr
Reserves₹242 Cr₹441 Cr₹542 Cr₹578 Cr₹652 Cr₹673 Cr
Borrowings₹108 Cr₹44 Cr₹47 Cr₹126 Cr₹222 Cr₹215 Cr
Other liabilities₹72 Cr₹73 Cr₹90 Cr₹99 Cr₹129 Cr₹154 Cr
Total liabilities₹436 Cr₹574 Cr₹696 Cr₹820 Cr₹1.0k Cr₹1.1k Cr
Fixed assets₹239 Cr₹262 Cr₹376 Cr₹477 Cr₹579 Cr₹623 Cr
Capital work in progress₹12 Cr₹15 Cr₹17 Cr₹11 Cr₹46 Cr₹14 Cr
Investments₹9 Cr₹17 Cr₹52 Cr₹38 Cr₹38 Cr₹22 Cr
Other assets₹177 Cr₹281 Cr₹251 Cr₹294 Cr₹355 Cr₹399 Cr
Total assets₹436 Cr₹574 Cr₹696 Cr₹820 Cr₹1.0k Cr₹1.1k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

What the price assumes

Growth trap

To justify its price of ₹676, this stock must grow earnings at 20% every year for 7 years. Our analysis caps realistic growth at ~-3%. At that growth it is worth ₹193 — downside of 71%.

Growth the price implies
20.1% a year
for 7 years, fading to 4%
It has actually compounded at
-3.5% a year
net profit, FY23–FY26 · EPS -3.3%
The gap
0.2 pp
-71% downside if it only repeats history
Price today ₹676.45 Value at the reference growth ₹193.15

Change the assumptions yourself →

All earnings calls (6)

Read the Q1 FY27 call →